Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00315588 · ClinicalTrials.gov registry record · Phase 2
Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation
A Phase 2 study of Diabetes Mellitus, Type 1, sponsored by Rodolfo Alejandro.
- Completed
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT00315588: Completed Phase 2 study of Diabetes Mellitus, Type 1, sponsored by Rodolfo Alejandro.
NCT00315588 is a Phase 2 study of Diabetes Mellitus, Type 1 that has completed, run by Rodolfo Alejandro. The registered enrollment target is 7 participants, below the 1,266-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00315588, a Phase 2 study of Diabetes Mellitus, Type 1, has completed, sponsored by Rodolfo Alejandro.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to reverse hyperglycemia and insulin dependency, by islet cell transplantation, in patients with type 1 diabetes mellitus who have a stable kidney allograft.
Primary Outcome
Number of Participants who Achieved Insulin Independence at 1 Year
Conditions Studied
Interventions
- DRUG Islet Transplantation
Study Locations (1)
Florida
- Diabetes Research Institute - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2000-12 |
| Est. Completion | 2014-05 |
| Phase | Phase 2 |
What the finished NCT00315588 record still lists
NCT00315588 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,266-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Diabetes Mellitus, Type 1 appearing as the primary indexed condition, and to 1 intervention - of which Islet Transplantation is the first listed.
NCT00315588 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT00315588 about?
NCT00315588 is a clinical study titled "Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation". The purpose of this study is to reverse hyperglycemia and insulin dependency, by islet cell transplantation, in patients with type 1 diabetes mellitus who have a stable kidney allograft.
What is the current status of trial NCT00315588?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2000-12. Estimated completion is 2014-05.
What conditions does trial NCT00315588 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 1.
What interventions are being tested in trial NCT00315588?
The interventions under investigation include: Islet Transplantation (DRUG).
Who is sponsoring clinical trial NCT00315588?
This trial is sponsored by Rodolfo Alejandro, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00315588 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 1
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00315588's enrollment target sits among peer trials
7 118th of 118 the lowest of 118 other Diabetes Mellitus, Type 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Islet Transplantation in Type 1 Diabetic Kidney Allograft
RECRUITING · Phase 2
-
Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes
RECRUITING · Phase 2
-
Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec
ACTIVE NOT RECRUITING · Phase 2
-
Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients
ACTIVE NOT RECRUITING · Phase 2
-
Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)
ACTIVE NOT RECRUITING · Phase 2
-
Comparison of Hepatic Directed Vesicle (HDV)-Insulin Lispro Versus Insulin Lispro to Further Improve Glycemic Control
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia